dimanche 15 novembre 2026
RechercherExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· November 25, 2025

Stock market today: Dow, S&P 500, Nasdaq mixed with retail sales, inflation data in focus

View original at finance.yahoo.com
Stock market today: Dow, S&P 500, Nasdaq mixed with retail sales, inflation data in focus US stocks wobbled Tuesday, struggling to build on a broad tech-led rebound fueled by growing optimism that the Federal Reserve will deliver a rate cut next month as delayed economic data provided glimpses into consumer spending an…
Opening lines of the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Institutional investors have stopped allocating into bitcoin as indicated by ETF outflows

    80% confidence
  • Markets are pricing in a more than 80% probability of a quarter-point interest-rate cut in December

    80% confidence
  • The legacy of DOGE may see companies do away with euphemisms for mass layoffs

    80% confidence
  • Bitcoin ETFs have turned into sellers and markets will struggle to stay up or rebound as long as they keep selling

    80% confidence
  • Sales were driven by strong results across computing, gaming, and mobile phones

    80% confidence
  • The grand promise of AI for the enterprise is running a business without employees

    80% confidence
  • DOGE opened the Overton window for any manager to perceive their workforce as too large

    80% confidence
  • Advocating for easing in interest rates

    80% confidence

Data points we hold from this source

Bitcoin · etf outflows3.5 billion_USD

Cité dans ces articles de Via News

Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Un éditeur vérifie les conflits entre sources avant de les publier ici.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,959
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,959 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com

Données de travail, pas l’article final. Voici ce que notre IA a lu et extrait des documents sources jusqu’ici. Notre méthode